Exempt from child-resistant packaging:

Rationale

Nitroglycerin sublingual tablets are exempt from child-resistant packaging.

Nitroglycerin sublingual tablets are specifically exempt from child-resistant packaging requirements due to their critical use in emergency situations for patients with angina pectoris. This exemption ensures that patients can access their medication quickly during a medical crisis without barriers that could delay treatment.

A (Methotrexate tablets) YOUR ANSWER

Methotrexate is a medication used to treat certain types of cancer and autoimmune diseases. It is considered hazardous and can be toxic if ingested improperly, making it subject to child-resistant packaging regulations to prevent accidental ingestion by children.

B (HCTZ tablets) YOUR ANSWER

Hydrochlorothiazide (HCTZ) is a diuretic used to manage high blood pressure and fluid retention. Given its common use and potential side effects, it is also required to have child-resistant packaging to safeguard against accidental consumption by children.

D (Isosorbide mononitrate) YOUR ANSWER

Isosorbide mononitrate is prescribed for the prevention of angina attacks. Similar to methotrexate and HCTZ, it is included in packaging regulations due to its potential risks, ensuring that it remains inaccessible to children who might accidentally ingest it.

Conclusion

Child-resistant packaging regulations are designed to protect children from potentially harmful medications. While many drugs, including methotrexate, HCTZ, and isosorbide mononitrate, fall under these regulations due to safety concerns, nitroglycerin sublingual tablets are uniquely exempt to facilitate rapid access in emergencies. Understanding these exemptions is crucial for both patient safety and effective emergency response.

Exempt from child-resistant packaging:

Nitroglycerin sublingual tablets are exempt from child-resistant packaging.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test